Dear Sir, Please find the attached below the appointment of Company Secretary and Compliance Officer with effect form 1-12-2025. Kindly update the same at your end and oblige us. Director
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Colinz Laboratories met on 27th November 2025 and approved two items. First, Ms. Falguni Kumawat (ICSI Membership No. A37989) has been appointed as Company Secretary and Compliance Officer with effect from 1st December 2025; she brings 10 years of experience in secretarial, legal and finance. Second, the Board granted authority to Whole-time Director & CEO Narayan Kutty Menon to identify buyers and negotiate terms for the proposed sale of the company's factory premises, which had already received shareholders' approval via postal ballot on 11th November 2025 under Section 180(1)(a) of the Companies Act, 2013. The meeting ran from 3:30 p.m. to 5:30 p.m.
The KMP appointment is routine governance housekeeping and unlikely to move the stock. The more material takeaway is the active progress on the factory premises sale — shareholders had already approved it, and management is now empowered to find buyers and finalize terms, which could lead to a meaningful asset divestment in coming months.